Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA allows companies to distribute articles on off-label use

This article was originally published in SRA

Executive Summary

The US Food and Drug Administration has finalised controversial guidance that permits drug and medical device manufacturers to disseminate information to healthcare professionals on the off-label uses of their approved products by reprinting articles in medical and scientific journals1,2. The document contains recommendations outlining the approach that the agency wants companies to follow in printing and distributing such articles.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS114174

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel